HEICO CORP

Republicans’ agenda in Congress stalls with their majorities in peril - The Spokesman-Review

As Trump commands 250th stage, Democrats offer their vision of patriotism

Two dead after taking their own lives in Rio Rancho

2 High-Flying Stocks with Competitive Advantages and 1 We Turn Down

Expensive stocks typically earn their valuations through superior growth rates that other companies simply can’t match. The flip side though is that these lofty expectations make them particularly susceptible to drawdowns when market sentiment shifts.

8 Health Care Stocks Whale Activity In Today’s Session

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner. Traders often

AT&T vs Verizon: The Better Dividend Stock For 2026

AT&T (NYSE:T) and Verizon (NYSE:VZ) both closed transformative fiber acquisitions early this year and just delivered Q1 2026 results that show two telecom giants racing toward the same convergence prize from very different starting points. AT&T is running an established playbook. Verizon is executing a turnaround under a brand new CEO. The quarter makes their ... AT&T vs Verizon: The Better Dividend Stock For 2026

How to Enjoy Retirement Without Spending Your Children’s Inheritance

Many retirees spent forty years sacrificing for their children. Then retirement arrives and they’re told, “You’ve earned it. Spend it.” The problem is that every vacation, new car, home renovation, or generous dinner can feel like it comes directly out of what the next generation might someday receive. Few parents want to live frugally just ... How to Enjoy Retirement Without Spending Your Children’s Inheritance

2 Large-Cap Stocks to Keep an Eye On and 1 We Ignore

Large-cap stocks have the power to shape entire industries thanks to their size and widespread influence. With such vast footprints, however, finding new areas for growth is much harder than for smaller, more agile players.

[Latest] Global Antidiabetic Drugs Market Size/Share Worth USD 309.84 Billion by 2035 at a 11.62% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

[220+ Pages Latest Report] According to a market research study published by Healthcare Foresights, the demand analysis of Global Antidiabetic Drugs Market size & share revenue was valued at approximately USD 103.21 Billion in 2025 and is expected to reach USD 115.02 Billion in 2026 and is expected to reach around USD 309.84 Billion by 2035, at a CAGR of 11.62% between 2026 and 2035. The key market players listed in the report with their sales, revenues and strategies are Eli Lilly and Company,

Kymera Therapeutics (KYMR) Stock Gets Fair Value Bump After KT 621 Timeline Shift

Kymera Therapeutics now carries an updated fair value estimate of US$123.76, a modest step up from US$119.19 that has drawn attention to how analysts are fine tuning their price targets. Much of the recent commentary links these changes to earlier than expected completion of the BROADEN2 trial, a pulled forward KT-621 readout, and fresh views on how much of that opportunity belongs in Kymera Therapeutics' valuation today. As you read on, you will see how these moving pieces fit together and...